Cost-benefit analysis of sheep and goat brucellosis vaccination with Rev.1 in the North of Portugal from 2000 to 2005;Análise de custo-benefício da vacinação com Rev.1 da brucelose ovina e caprina no Norte de Portugal entre 2000 e 2005

Arquivo Brasileiro de Medicina Veterinaria e Zootecnia

Volumn 63, Issue 1, 2011, Pages 1-5

  Coelho, A M ^a   Pinto, M L ^b   Coelho, A C ^b  

^a Divisao de Intervencao Veterinaria de Vila Real   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Brucellosis; Cost benefit; Vaccination

Indexed keywords

ANIMALIA; BOVIDAE; CAPRA HIRCUS; OVIS ARIES;

EID: 79955443994     PISSN: 01020935     EISSN: 16784162     Source Type: Journal    
DOI: 10.1590/S0102-09352011000100001     Document Type: Article

References (18)

1. AL-MAJALI, A.M. Seroepidemiology of caprine brucellosis in Jordan. Small Rum. Res., v.58, p.13-18, 2005.
2. AMADOR, R.; VALENTIM, R. Brucelose. Lisboa: DGV, 2000.
3. ARIZA, J.; CORREDOIRA, J.; PALLARES, R. et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin. Infect. Dis., v.20, p.1241-1249, 1995.
4. BLASCO, J.M. A Review of the use of B. melitensis Rev. 1 vaccine in adult sheep and goats. Prev. Vet. Med., v.31, p.275-283, 1997.
5. BLASCO, J.M. Classical and new generation vaccinnes against B. melitensis infection in small ruminants. In: INTERNATIONAL RESEARCH CONFERENCE FOR BRUCELLOSIS IN SMALL RUMINANTS, 2005, Skopje. Proceedings...Skopje, Macedonia, 2005.
6. BLASCO, J.M. Existing and future vaccines against brucellosis in small ruminants. Small Rum. Res., v.62, p.33-37, 2006.
7. BOSSERAY, N. Control methods and thresholds of acceptability for antibrucella vaccines. Dev. Biol. Stand., v.79, p.121-128, 1992.
8. CORBEL, M.J. Brucellosis: an overview. Emerg. Infect. Dis., v.3, p.213-221, 1997.
9. EUROPEAN COMMISSION. Brucellosis in sheep and goats (Brucella melitensis). Scientific Committee on Animal Health and Animal Welfare, 2001.
10. KUMBE, I.; PRANVERA, R.; LULJETA, D. et al. Control strategy of brucellosis in small ruminants in Albania based on its serological profile. In: INTERNATIONAL RESEARCH CONFERENCE FOR BRUCELLOSIS IN SMALL RUMINANTS, 2005, Skopje. Proceedings...Skopje, Macedonia, 2005.
11. LEVENSTEIN, C., DUNN, M.L. Show me the money cost-benefit analysis in the work environment. New Solutions, v.15, p.261-276, 2005.
12. NICOLETTI, P. Vaccination against Brucella. Adv. Biotechnol. Proc., v.13, p.147-168, 1990.
13. OFFICE INTERNATIONAL DES ÉPIZOOTIES. Caprine and ovine brucellosis, 2009. Available in: . Accessed in: July 5, 2009.
14. ROTH, F.; ZINSSTAG, J.; ORKHON, D. et al. Human health benefits from livestock vaccination for brucellosis: case study. Bull. World Health Organ., v.81, p.867-876, 2003.
15. SCHARP, D.W.; AL KHALAF, S.A.S., AL MUHANNA, M.W. et al. Use of mass vaccination with a reduced dose of Rev. 1 vaccine for Brucella melitensis control in a population of small ruminants. Trop. Anim. Health Prod., v.31, p.135-141, 1999.
16. SHELDON, R.; O'BRIAEN, B.J.; BLACKHOUSE, G. et al. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator. The Canadian implantable defribilattor study. Circulation, v.2, p.1622-1626, 2001.
17. TAKKOUCHE, E.B.; OTERO, J.J.G. La nueva cara de la brucellosis humana: epidemiología, diagnóstico, clínica y prevención. Santiago de Compostela: Universidade, Serviço de Publicações e Intercâmbio Científico, 1996.
18. WORLD HEALTH ORGANIZATION. The Development of New/Improved brucellosis vaccines. Geneva: WHO/EMC/ZDI/98.14, 1997.